Consolidated Statement Of Cash Flows

K Pharma,Inc. - Filing #7269885

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-942,044,000 JPY
456,310,000 JPY
Interest and dividends received
265,000 JPY
16,000 JPY
Income taxes paid
-41,940,000 JPY
-1,901,000 JPY
Net cash provided by (used in) operating activities
-983,719,000 JPY
454,425,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-14,490,000 JPY
-9,803,000 JPY
Net cash provided by (used in) investing activities
-14,490,000 JPY
-11,099,000 JPY
Cash flows from financing activities
Proceeds from issuance of shares
JPY
1,496,325,000 JPY
Net cash provided by (used in) financing activities
JPY
1,486,235,000 JPY
Other, net
JPY
-90,000 JPY
Net increase (decrease) in cash and cash equivalents
-998,210,000 JPY
1,929,560,000 JPY
Cash and cash equivalents
2,268,198,000 JPY
3,266,408,000 JPY
1,336,847,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.